Already know your catalog numbers?
For sensitive detection of the most frequently occurring somatic mutations in the EGFR oncogene in less than 4 hours
For qualitative detection of actionable alterations in the FGFR3 gene
For quantitative detection of mutations in exons 3, and 4 of the human KRAS oncogene, and exons 2, 3, and 4 of the human NRAS oncogene
For sensitive detection of clinically proven somatic mutations in the EGFR oncogene, on cfDNA (circulating-free DNA) extracted from plasma samples
For clinically reliable determination of the PITX2 methylation ratio in lymph node-positive, estrogen receptor-positive and HER2-negative high-risk breast cancer patient tissue samples